TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Theriva Biologics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.20−0.00 (-1.54%)
Close on Oct 19, 2026
- Market cap
- $9.39M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 26, 2024 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Aug 26, 2024 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jul 25, 2022 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jul 11, 2022 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Nov 8, 2018(first seen in filings) | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Aug 13, 2018 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Apr 25, 2007 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |